TWO · 4139.TWO
Ma Kuang Healthcare Holding Limited
NT$41.95-NT$1.55 (-3.56%)
Ma Kuang Healthcare Holding Limited’s quoted price sits in the upper half of its reported 52-week range, 7.8% below the high.
Loading market information…
TWO · 6665.TWO · TWD
Stock price, dividends
Quote as of Oct 30, 2026, 06:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · TWD. Historical prices are not a forecast.
Healthconn Corp.’s quoted price sits in the lower half of its reported 52-week range, 31.97% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Healthconn Corp.’s forward annual dividend is NT$0.15 per share, paid annual. The forward yield is 0.89% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
Established in 2009 and headquartered in Taipei, Taiwan, Healthconn Corp. specializes in delivering bespoke disease prevention and holistic health management solutions. The company provides a diverse range of services catering to both individual clients and corporate organizations. These encompass various health promotion initiatives, offering expert guidance on aspects like nutrition, physical activity, stress reduction, and optimizing sleep patterns. Beyond general wellness, Healthconn extends its expertise to more specialized areas, including nutritional genomics, crafting customized exercise prescriptions, enhancing overall lifestyle, and developing personalized health improvement blueprints. Clients also benefit from dedicated health managers, all focused on achieving measurable and results-oriented health outcomes. Furthermore, Healthconn offers a suite of advanced diagnostic and assessment services. This includes precise food safety screening, oncogene detection, bacteriological examinations, and molecular biology analysis. The firm also utilizes interdisciplinary insights for cutting-edge health risk assessments, provides strategic health management consulting, and offers programs for weight control, alongside its unique "healthconn awareness journey." A flagship offering is their "Smart Health 365 Seamless Health Management," an integrated, year-round health management program designed for continuous well-being.
Latest available per-share figures in TWD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:42 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
NT$41.95-NT$1.55 (-3.56%)
Ma Kuang Healthcare Holding Limited’s quoted price sits in the upper half of its reported 52-week range, 7.8% below the high.
NT$32.25-NT$0.90 (-2.71%)
Andros Pharmaceuticals Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.82% below the high.
NT$30.15NT$0.00 (0.0%)
Concord Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.75% below the high.
NT$15.40-NT$0.65 (-4.05%)
AmCad BioMed Corporation’s quoted price sits in the upper half of its reported 52-week range, 18.3% below the high.
NT$15.85-NT$0.20 (-1.25%)
Radiant Innovation Inc.’s quoted price sits in the lower half of its reported 52-week range, 24.7% below the high.
NT$6.35-NT$0.34 (-5.08%)
PlexBio Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 59.81% below the high.
NT$16.90+NT$0.40 (+2.42%)
SynCore Biotechnology Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 41.32% below the high.
NT$6.22-NT$0.18 (-2.81%)
General Biologicals Corporation’s quoted price sits in the lower half of its reported 52-week range, 64.05% below the high.
